136 related articles for article (PubMed ID: 32709151)
1. Characterization of mTOR Activity and Metabolic Profile in Pediatric Rhabdomyosarcoma.
Felkai L; Krencz I; Kiss DJ; Nagy N; Petővári G; Dankó T; Micsík T; Khoor A; Tornóczky T; Sápi Z; Sebestyén A; Csóka M
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32709151
[TBL] [Abstract][Full Text] [Related]
2.
Mohás A; Krencz I; Váradi Z; Arató G; Felkai L; Kiss DJ; Moldvai D; Sebestyén A; Csóka M
Pathol Oncol Res; 2022; 28():1610231. PubMed ID: 35392503
[TBL] [Abstract][Full Text] [Related]
3. RICTOR/mTORC2 affects tumorigenesis and therapeutic efficacy of mTOR inhibitors in esophageal squamous cell carcinoma.
Lu Z; Shi X; Gong F; Li S; Wang Y; Ren Y; Zhang M; Yu B; Li Y; Zhao W; Zhang J; Hou G
Acta Pharm Sin B; 2020 Jun; 10(6):1004-1019. PubMed ID: 32642408
[TBL] [Abstract][Full Text] [Related]
4. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
[TBL] [Abstract][Full Text] [Related]
5. Rapamycin-insensitive companion of mTOR (RICTOR) amplification defines a subset of advanced gastric cancer and is sensitive to AZD2014-mediated mTORC1/2 inhibition.
Kim ST; Kim SY; Klempner SJ; Yoon J; Kim N; Ahn S; Bang H; Kim KM; Park W; Park SH; Park JO; Park YS; Lim HY; Lee SH; Park K; Kang WK; Lee J
Ann Oncol; 2017 Mar; 28(3):547-554. PubMed ID: 28028034
[TBL] [Abstract][Full Text] [Related]
6. mTOR activity and its prognostic significance in human colorectal carcinoma depending on C1 and C2 complex-related protein expression.
Sticz T; Molnár A; Márk Á; Hajdu M; Nagy N; Végső G; Micsik T; Kopper L; Sebestyén A
J Clin Pathol; 2017 May; 70(5):410-416. PubMed ID: 27729429
[TBL] [Abstract][Full Text] [Related]
7. Elevated Rictor expression is associated with tumor progression and poor prognosis in patients with gastric cancer.
Bian Y; Wang Z; Xu J; Zhao W; Cao H; Zhang Z
Biochem Biophys Res Commun; 2015 Aug; 464(2):534-40. PubMed ID: 26159923
[TBL] [Abstract][Full Text] [Related]
8. Expression of mTORC1/2-related proteins in primary and brain metastatic lung adenocarcinoma.
Krencz I; Sebestyén A; Fábián K; Márk Á; Moldvay J; Khoor A; Kopper L; Pápay J
Hum Pathol; 2017 Apr; 62():66-73. PubMed ID: 28025080
[TBL] [Abstract][Full Text] [Related]
9. Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1.
Guertin DA; Stevens DM; Thoreen CC; Burds AA; Kalaany NY; Moffat J; Brown M; Fitzgerald KJ; Sabatini DM
Dev Cell; 2006 Dec; 11(6):859-71. PubMed ID: 17141160
[TBL] [Abstract][Full Text] [Related]
10. Targeting of mTORC2 may have advantages over selective targeting of mTORC1 in the treatment of malignant pheochromocytoma.
Zhang X; Wang X; Xu T; Zhong S; Shen Z
Tumour Biol; 2015 Jul; 36(7):5273-81. PubMed ID: 25666752
[TBL] [Abstract][Full Text] [Related]
11. Synergistic Effects between mTOR Complex 1/2 and Glycolysis Inhibitors in Non-Small-Cell Lung Carcinoma Cells.
Jiang S; Zou Z; Nie P; Wen R; Xiao Y; Tang J
PLoS One; 2015; 10(7):e0132880. PubMed ID: 26176608
[TBL] [Abstract][Full Text] [Related]
12. Loss of mTOR signaling affects cone function, cone structure and expression of cone specific proteins without affecting cone survival.
Ma S; Venkatesh A; Langellotto F; Le YZ; Hall MN; Rüegg MA; Punzo C
Exp Eye Res; 2015 Jun; 135():1-13. PubMed ID: 25887293
[TBL] [Abstract][Full Text] [Related]
13. Targeting mTORC2 component rictor inhibits cell proliferation and promotes apoptosis in gastric cancer.
Bian YH; Xu J; Zhao WY; Zhang ZZ; Tu L; Cao H; Zhang ZG
Am J Transl Res; 2017; 9(9):4317-4330. PubMed ID: 28979705
[TBL] [Abstract][Full Text] [Related]
14. mTORC2 promotes type I insulin-like growth factor receptor and insulin receptor activation through the tyrosine kinase activity of mTOR.
Yin Y; Hua H; Li M; Liu S; Kong Q; Shao T; Wang J; Luo Y; Wang Q; Luo T; Jiang Y
Cell Res; 2016 Jan; 26(1):46-65. PubMed ID: 26584640
[TBL] [Abstract][Full Text] [Related]
15. Cytoplasmic and nuclear distribution of the protein complexes mTORC1 and mTORC2: rapamycin triggers dephosphorylation and delocalization of the mTORC2 components rictor and sin1.
Rosner M; Hengstschläger M
Hum Mol Genet; 2008 Oct; 17(19):2934-48. PubMed ID: 18614546
[TBL] [Abstract][Full Text] [Related]
16. mTORC2 (Rictor) in Alzheimer's Disease and Reversal of Amyloid-β Expression-Induced Insulin Resistance and Toxicity in Rat Primary Cortical Neurons.
Lee HK; Kwon B; Lemere CA; de la Monte S; Itamura K; Ha AY; Querfurth HW
J Alzheimers Dis; 2017; 56(3):1015-1036. PubMed ID: 28035937
[TBL] [Abstract][Full Text] [Related]
17. Correlation between immunohistochemistry and RICTOR fluorescence in situ hybridization amplification in small cell lung carcinoma.
Krencz I; Sebestyen A; Papay J; Lou Y; Lutz GF; Majewicz TL; Khoor A
Hum Pathol; 2019 Nov; 93():74-80. PubMed ID: 31454632
[TBL] [Abstract][Full Text] [Related]
18. Mtor-Fanconi Anemia DNA Damage Repair Pathway in Cancer.
Guo F
J Oncobiomarkers; 2014; 2(2):. PubMed ID: 25621286
[TBL] [Abstract][Full Text] [Related]
19. mTOR has a developmental stage-specific role in mitochondrial fitness independent of conventional mTORC1 and mTORC2 and the kinase activity.
Kalim KW; Zhang S; Chen X; Li Y; Yang JQ; Zheng Y; Guo F
PLoS One; 2017; 12(8):e0183266. PubMed ID: 28813526
[TBL] [Abstract][Full Text] [Related]
20. PTEN negatively regulates mTORC2 formation and signaling in grade IV glioma via Rictor hyperphosphorylation at Thr1135 and direct the mode of action of an mTORC1/2 inhibitor.
Bhattacharya K; Maiti S; Mandal C
Oncogenesis; 2016 May; 5(5):e227. PubMed ID: 27239959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
